OverviewThe PhD in Digital Cardiovascular Medicine, Pathology, and Cutting-Edge Therapeutics at Sapienza University of Rome develops researchers who can translate data-driven methods into real cardiovascular diagnostics and therapies. The programme combines advanced cardiovascular research with artificial intelligence, imaging analytics, and tele-monitoring technologies.Key factsA distinctive feature of DigiCardioPaTh is its international consortium network, enabling an interdisciplinary and transnational research experience. Students complete a minimum 1-year period of stay across agreed consortium campuses.
The PhD in Digital Cardiovascular Medicine, Pathology, and Cutting-Edge Therapeutics at Sapienza University of Rome aims to cultivate researchers capable of transforming data-driven methodologies into practical cardiovascular diagnostics and therapies. This program merges advanced cardiovascular research with artificial intelligence, imaging analytics, and tele-monitoring technologies.
The doctoral training integrates advanced courses with supervised research, culminating in a PhD thesis. The curriculum is designed to enhance methodological and technical skills essential for digital cardiovascular research.
Research component: Candidates will conduct original research under supervision, involving data collection, computational and analytical work, validation, and dissemination of findings through scientific outputs.
International experience: The consortium structure promotes research collaboration across partner campuses, requiring a minimum one-year stay at designated locations.
Applicants must possess a Master’s degree (or equivalent recognized qualification) relevant to the program's research focus.
Selection process typically includes:
Graduates of this program are well-prepared for careers in academia, research institutions, healthcare organizations, and the pharmaceutical industry. They will have the skills necessary to contribute to the advancement of digital cardiovascular medicine and related fields, driving innovation in diagnostics and therapeutic approaches.
Shortlist scholarships and plan your application — free guidance from our advisors.